Its crazy the way people on HC interpret these kinds of announcements. We will not be seeing anything of real importance for at lest 18-24months. DYOR and don't get sucked in by all the folks on here trying to 'wish' their way to a Disallowed.
Study Type :Interventional (Clinical Trial)
Estimated Enrollment :32
participantsAllocation:Non-Randomized
Intervention Model:Sequential
AssignmentMasking:None (Open Label)
Primary Purpose:Treatment
Official Title:An Open Label, Multi-Center, Dose Escalation/Expansion, Phase 1 Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer
EstimatedStudy Start Date :October 30, 2020
Estimated Primary Completion Dateecember 2022
Estimated Study Completion Date
Ann: Imugene First Patient Dosed in PD1-VAXX Clinical Trial, page-13
-
- There are more pages in this discussion • 112 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |